Stockscreener 앱 받기
192.88
1.76%
3.33
시간 외 거래:
192.88
Ligand Pharmaceuticals Inc 주식(LGND)의 최신 뉴스
LGND: 2025 Analyst Day - Zacks Small Cap Research
Market Leaders: Is Ligand Pharmaceuticals Incorporated stock safe for conservative investorsPortfolio Gains Summary & Free Technical Confirmation Trade Alerts - moha.gov.vn
CFO Espinoza Files To Sell 1,804 Of Ligand Pharmaceuticals Inc [LGND] - TradingView — Track All Markets
Stifel Maintains Ligand Pharmaceuticals IncorporatedEquity Right (LGNDZ) Buy Recommendation - Nasdaq
RBC Capital Maintains Ligand Pharmaceuticals IncorporatedEquity Right (LGNXZ) Outperform Recommendation - Nasdaq
RBC Capital Maintains Ligand Pharmaceuticals (LGND) Outperform Recommendation - Nasdaq
Benchmark reaffirms Buy rating on Ligand Pharma stock with $220 target - Investing.com Canada
Oppenheimer reiterates Outperform rating on Ligand Pharma stock at $275 By Investing.com - Investing.com Canada
LGND: RBC Capital Raises Price Target, Maintains 'Outperform' Ra - GuruFocus
LGND: Stifel Raises Price Target to $230, Maintains 'Buy' Rating - GuruFocus
Stifel Nicolaus Boosts Ligand Pharmaceuticals (NASDAQ:LGND) Price Target to $230.00 - MarketBeat
RBC Lifts Price Target on Ligand Pharmaceuticals to $235 From $234, Keeps Outperform Rating - marketscreener.com
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance - 富途牛牛
CFO Espinoza Surrenders 1,862 Of Ligand Pharmaceuticals Inc [LGND] - TradingView — Track All Markets
Ligand Pharma stock price target raised to $230 by Stifel on growth outlook - Investing.com Canada
Citigroup Initiates Coverage of Ligand Pharmaceuticals (LGND) with Buy Recommendation - Nasdaq
LIGAND PHARMACEUTICALS INCINTRODUCES 2026 REVENUE GUIDANCE OF $245-$285 MLN - 富途牛牛
Citigroup Initiates Coverage On LGND with a Buy Rating | LGND St - GuruFocus
Ligand Pharma sets 2026 outlook as Citi starts at buy on valuation - MSN
Major Decision: Jason Aryeh Exercises Options, Realizing $234K At Ligand Pharmaceuticals - Benzinga
Ligand Pharmaceuticals (NASDAQ:LGND) Releases FY 2026 Earnings Guidance - MarketBeat
Ligand Pharmaceuticals (NASDAQ:LGND) Coverage Initiated by Analysts at Citigroup - MarketBeat
Ligand Pharmaceuticals Stock (LGND) Opinions on 2025 Investor Day and 2026 Guidance - Quiver Quantitative
Ligand Pharmaceuticals Incorporated Provides Earnings Guidance for the Year 2026 - marketscreener.com
Citigroup Initiates Ligand Pharmaceuticals at Buy With $270 Price Target - marketscreener.com
Ligand (LGND) Highlights Strategic Advances and Growth Prospects at Investor Day - GuruFocus
(LGND) Ligand Pharmaceuticals Expects Full Year 2025 Core Revenue Range $225M to $235M - marketscreener.com
(LGND) Ligand Pharmaceuticals Expects Full Year 2026 Core Adjusted EPS Range $8 to $9, vs. FactSet Est of $7.97 - marketscreener.com
(LGND) Ligand Pharmaceuticals Expects Full Year 2026 Revenue Range $245M to $285M, vs. FactSet Est of $259.2M - marketscreener.com
LGND FinancialsIncome Statement - Quiver Quantitative
Ligand Pharmaceuticals Provides 2026 Revenue Guidance of $245 Million to $285 Million with Increased Royalty Revenue Outlook - Quiver Quantitative
Citigroup initiates coverage of Ligand Pharmaceuticals IncorporatedEquity Right (LGNYZ) with buy recommendation - MSN
Dir Aryeh Acquires 2,034 Of Ligand Pharmaceuticals Inc [LGND] - TradingView — Track All Markets
CEO Davis Gifts 130 Of Ligand Pharmaceuticals Inc [LGND] - TradingView — Track All Markets
Is Ligand Pharmaceuticals Incorporated LGDN a good long term investmentGlobal Trade Effects & Demo Trading Rooms Open Daily - earlytimes.in
Ligand Pharmaceuticals IncorporatedEquity Right (LGNXZ) Price Target Increased by 25.41% to 0.00 - Nasdaq
Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells $91,457.28 in Stock - MarketBeat
Why analysts upgrade Ligand Pharmaceuticals Incorporated stockJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - Newser
Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI™ (berdazimer) Topical Gel, 10.3% - GlobeNewswire Inc.
Can Ligand Pharmaceuticals Incorporated stock double in next 5 yearsInsider Selling & Weekly Chart Analysis and Guides - Newser
Ligand Pharmaceuticals Earnings Notes - Trefis
Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceutica - GuruFocus
A Look Into Ligand Pharmaceuticals Inc's Price Over Earnings - Benzinga
Ligand Pharmaceuticals Incorporated $LGND Stake Decreased by Prudential Financial Inc. - MarketBeat
Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Granite Investment Partners LLC - MarketBeat
Will Ligand Pharmaceuticals Incorporated (LGDN) stock hit analyst forecastsWeekly Market Outlook & Stock Portfolio Risk Control - Newser
Will Ligand Pharmaceuticals Incorporated stock benefit from sector rotationTreasury Yields & Real-Time Volume Triggers - Newser
Ligand Pharmaceuticals Incorporated $LGND Shares Purchased by Russell Investments Group Ltd. - MarketBeat
Is Ligand Pharmaceuticals Incorporated (LGDN) stock at risk of policy regulationBreakout Watch & AI Based Buy/Sell Signal Reports - Newser
How strong is Ligand Pharmaceuticals Incorporated (LGDN) stock earnings growth - Newser
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Ligand Pharmaceuticals (LGND) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ligand Pharmaceuticals Incorporated $LGND Shares Bought by Legal & General Group Plc - MarketBeat
Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Loomis Sayles & Co. L P - MarketBeat
Ligand Pharmaceuticals Incorporated $LGND Shares Sold by SG Americas Securities LLC - MarketBeat
Advantage Alpha Capital Partners LP Purchases New Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Portfolio Recap: Why Ligand Pharmaceuticals Incorporated stock could outperform in 2025 - moha.gov.vn
Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - Yahoo! Finance Canada
Peering Into Ligand Pharmaceuticals Inc's Recent Short Interest - Benzinga
Will Ligand Pharmaceuticals Incorporated stock deliver better than expected guidance2025 Volatility Report & Reliable Volume Spike Trade Alerts - moha.gov.vn
This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know - AOL.com
Ligand Pharmaceuticals Incorporated $LGND Stake Boosted by Geode Capital Management LLC - MarketBeat
Ligand Pharma stock maintains Outperform rating at RBC ahead of Investor Day By Investing.com - Investing.com Canada
0.36%
1.05%
자본화:
|
볼륨(24시간):